FDA clears Intel in-home medical device

Intel has received the FDA’s 510(k) market clearance for its personal health system, the Intel Health Guide, a care management tool for healthcare professionals who manage patients with chronic conditions.

The Santa Clara, Calif.-based Intel said its Health Guide combines an in-home patient device, as well as an online interface allowing clinicians to monitor patients and remotely manage care. The product offers interactive tools for personalized care management and integrates vital sign collection, patient reminders, multimedia educational content and feedback and communications tools, such as video conferencing and email.

The Health Guide can connect to specific models of wired and wireless medical devices, including blood pressure monitors, glucose meters, pulse oximeters, peak flow meters and weight scales, according to the company. The Health Guide stores and displays the collected information on a touch-screen and sends to a secure host server, where healthcare professionals can review the information. Patients using the Health Guide can monitor their health status and communicate with care teams about their condition.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.